Karen Kozarsky is the founder of SwanBio Therapeutics. SwanBio Therapeutics has raised $52M in total funding. Latest round: Series A.
Karen Kozarsky is the Chief Scientific Officer and Co-Founder of SwanBio Therapeutics, a company focused on developing gene therapy for inherited rare diseases, particularly utilizing adeno-associated virus (AAV) vectors. She has 30 years of experience in gene therapy, with previous roles at Vector BioPartners, REGENXBIO Inc., and GlaxoSmithKline Biopharm. SwanBio Therapeutics raised $52 million in an expanded Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library